A. Iop

577 total citations
22 papers, 374 citations indexed

About

A. Iop is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Iop has authored 22 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in A. Iop's work include Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). A. Iop is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). A. Iop collaborates with scholars based in Italy. A. Iop's co-authors include Salvatore Bonura, G. Cartei, Laura Doni, Paolo Tralongo, Rodolfo Mattioli, Francesco Di Costanzo, B. Massidda, Emiddio Barletta, Silvia Gasperoni and F. Recchia and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

A. Iop

22 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Iop Italy 9 283 152 69 60 50 22 374
Αναστάσιος Γκουντάκος Italy 10 219 0.8× 154 1.0× 92 1.3× 37 0.6× 175 3.5× 21 425
Nedal Bukhari Saudi Arabia 7 187 0.7× 91 0.6× 22 0.3× 72 1.2× 72 1.4× 22 339
Lucia Vassalli Italy 13 223 0.8× 151 1.0× 60 0.9× 42 0.7× 51 1.0× 30 420
A. Michelotti Italy 11 210 0.7× 100 0.7× 108 1.6× 63 1.1× 67 1.3× 15 372
Meinrad Mannhart Switzerland 9 304 1.1× 132 0.9× 36 0.5× 76 1.3× 45 0.9× 19 413
C. Haberl Germany 11 173 0.6× 158 1.0× 41 0.6× 83 1.4× 54 1.1× 19 419
G. Krajnik Austria 9 250 0.9× 136 0.9× 22 0.3× 26 0.4× 58 1.2× 19 374
Judit Kocsis Hungary 9 164 0.6× 79 0.5× 26 0.4× 45 0.8× 87 1.7× 38 341
Cédric Lecaille France 11 284 1.0× 143 0.9× 69 1.0× 123 2.0× 46 0.9× 21 449
Çağlayan Geredeli Türkiye 10 210 0.7× 108 0.7× 73 1.1× 61 1.0× 52 1.0× 49 304

Countries citing papers authored by A. Iop

Since Specialization
Citations

This map shows the geographic impact of A. Iop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Iop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Iop more than expected).

Fields of papers citing papers by A. Iop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Iop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Iop. The network helps show where A. Iop may publish in the future.

Co-authorship network of co-authors of A. Iop

This figure shows the co-authorship network connecting the top 25 collaborators of A. Iop. A scholar is included among the top collaborators of A. Iop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Iop. A. Iop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lello, Stefano, Ida Paris, Angelo Cagnacci, et al.. (2023). Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract. Gynecological Endocrinology. 39(1). 2162035–2162035. 6 indexed citations
2.
Lello, Stefano, Ida Paris, Angelo Cagnacci, et al.. (2023). Vasomotor symptoms in women treated for breast cancer: complementary and alternative medicine approaches including purified cytoplasm of pollen. Maturitas. 173. 90–91. 1 indexed citations
3.
Iop, A., et al.. (2021). Cytoplasmic pollen extract for treatment of menopausal symptoms in breast cancer patients: a case series report. European Journal of Gynaecological Oncology. 42(1). 45–45. 3 indexed citations
5.
Giordano, Guido, Antonio Febbraro, Michèle Milella, et al.. (2016). Impact of second-line treatment (2L T) in advanced pancreatic cancer (APDAC) patients (pts) receiving first line Nab-Paclitaxel (nab-P) + Gemcitabine (G): An Italian multicentre real life experience.. Journal of Clinical Oncology. 34(15_suppl). 4124–4124. 8 indexed citations
6.
Mustacchi, Giorgio, Fabio Puglisi, Diana Crivellari, et al.. (2015). Observational Study on Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer Patients. Future Oncology. 11(10). 1493–1500. 9 indexed citations
7.
Cataldi, Palmina, A. Iop, Miriam Isola, et al.. (2012). The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness. Human Pathology. 44(1). 122–132. 22 indexed citations
8.
Mustacchi, Giorgio, Annamaria Molino, Elena Fiorio, et al.. (2012). Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting.. Journal of Clinical Oncology. 30(15_suppl). 586–586. 2 indexed citations
9.
Doni, Laura, Alessandra Perin, Luigi Manzione, et al.. (2010). The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy. Critical Reviews in Oncology/Hematology. 77(1). 70–77. 8 indexed citations
10.
Mucciarini, Claudia, Stefano Bellentani, Giorgia Razzini, et al.. (2009). The role of contrast-enhanced ultrasound in detection of liver metastases from colorectal cancer: A prospective monocentric study. Journal of Clinical Oncology. 27(15_suppl). e15105–e15105. 2 indexed citations
11.
Bajetta, Emilio, Maria Di Bartolomeo, Roberto Buzzoni, et al.. (2007). Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. British Journal of Cancer. 96(3). 439–444. 32 indexed citations
12.
Cavanna, Luigi, Fabrizio Artioli, Claudio Codignola, et al.. (2006). Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV) in Patients With Metastatic Gastric Cancer (MGC). American Journal of Clinical Oncology. 29(4). 371–375. 52 indexed citations
13.
Cartei, G., Cosimo Sacco, Alessandra Bearz, et al.. (2006). Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapy. Annals of Oncology. 17. v47–v51. 1 indexed citations
14.
Costanzo, Francesco Di, Paolo Carlini, Laura Doni, et al.. (2005). Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). British Journal of Cancer. 93(2). 185–189. 78 indexed citations
15.
Iop, A., et al.. (2004). Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Annals of Oncology. 15(5). 712–720. 96 indexed citations
16.
Grossi, Francesco, Ornella Belvedere, C. Rossetto, et al.. (2004). Irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 007). Journal of Clinical Oncology. 22(14_suppl). 7363–7363. 3 indexed citations
17.
Terrosu, Giovanni, Carla Cedolini, Vittorio Bresadola, et al.. (2003). Preoperative chemoradiotherapy in cancer of the thoracic esophagus. Diseases of the Esophagus. 16(1). 9–16. 12 indexed citations
18.
Cartei, G., et al.. (1999). Cisplatin and gemcitabine in non-small-cell lung cancer. Annals of Oncology. 10. S57–S62. 14 indexed citations
20.
Iop, A., et al.. (1997). Mitomycin C, Cisplatin, and 5-Fluorouracil for Advanced and/or Recurrent Head and Neck Squamous Cell Carcinomas. American Journal of Clinical Oncology. 20(5). 515–518. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026